Neurologic clinical trial - Viela Bio Myasthenia Gravis INebilizumab Trial (MINT)

Status:

Start-up/Open

ClinicalTrials.gov:

NCT04524273

CONDITIONS: Myasthenia gravis, generalized myasthenia gravis  - TRIAL: A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 3 Study With Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults With Myasthenia Gravis

Drug

Inebilizumab

Phase

Phase 3

Condition

Myasthenia gravis generalized myasthenia gravis

Keywords

VIB0551.P3.S1 | Viela Bio | Inebilizumab